Loading...

Home
ETF
QURE

QURE

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

QURE News

FDA's Regulatory Reversal Boosts Biotech Sector

Jun 24 2026seekingalpha

uniQure Prices Public Offering at $225 Million

Jun 24 2026seekingalpha

uniQure N.V. Upsizes Public Offering to $225 Million

Jun 24 2026NASDAQ.COM

uniQure Prices Public Offering at $45.50 per Share, Raising $225 Million

Jun 24 2026Newsfilter

uniQure Proposes $150 Million Public Offering to Strengthen Balance Sheet

Jun 23 2026NASDAQ.COM

uniQure Launches $150M Underwritten Public Offering

Jun 22 2026seekingalpha

uniQure Achieves Major Regulatory Milestone for Gene Therapy

Jun 19 2026NASDAQ.COM

uniQure Releases Initial Data on Gene Therapy AMT-260

Jun 19 2026Newsfilter

Latest Wall Street Rating Updates

Jun 18 2026CNBC

uniQure Shares Surge After FDA Softens Stance on Gene Therapy

Jun 18 2026NASDAQ.COM

US Stocks Plunge as Tech Sector Weighs Down Market

Jun 18 2026NASDAQ.COM

uniQure's Gene Therapy AMT-130 Receives FDA Clearance

Jun 17 2026seekingalpha

Mixed Performance in US Stock Indices, Chipmakers Lead Gains

Jun 17 2026NASDAQ.COM

UniQure to Seek FDA Approval for Huntington's Gene Therapy

Jun 17 2026CNBC

Analysis of Significant Stock Movements in Various Companies

Jun 17 2026CNBC

UniQure to Seek Approval for Huntington's Gene Therapy

Jun 17 2026Newsfilter